Atlas Trials

Myeloid Malignancy

25 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Myeloid Malignancy

RecordFirmDate
Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms (NCT05455294)Jacqueline Garcia, MD2022-07-18
T-cell Receptor α/β Depleted Donor Lymphocyte Infusion (NCT05350163)Guenther Koehne2022-04-05
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML (NCT04501120)Ascentage Pharma Group Inc.2020-09-28
Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations (NCT04906031)First Affiliated Hospital of Jinan University2020-06-01
APR-246 in Combination With Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies (NCT04214860)Aprea Therapeutics2019-12-13
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant (NCT03850418)Henry Ford Health System2019-07-01
Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS (NCT03855371)Ruijin Hospital2018-01-10
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study (NCT02958462)Mayo Clinic2017-01-16
Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation (NCT01596699)University of California, San Francisco2012-05-24

Track Myeloid Malignancy automatically

Every clearance here is in the API, with alerts when new ones post.